Estonia - Estonia - Ravimiamet

medochemie limited - risperidoon - õhukese polümeerikattega tablett - 1mg 30tk; 1mg 10tk; 1mg 90tk; 1mg 120tk; 1mg 100tk

Estonia - Estonia - Ravimiamet

medochemie limited - risperidoon - õhukese polümeerikattega tablett - 2mg 10tk; 2mg 100tk; 2mg 30tk; 2mg 60tk; 2mg 50tk; 2mg 20tk; 2mg 90tk; 2mg 120tk

Estonia - Estonia - Ravimiamet

medochemie limited - risperidoon - õhukese polümeerikattega tablett - 3mg 30tk; 3mg 60tk; 3mg 50tk; 3mg 90tk; 3mg 20tk; 3mg 100tk

Estonia - Estonia - Ravimiamet

teva pharma b.v. - kvetiapiin - toimeainet prolongeeritult vabastav tablett - 300mg 60tk

Estonia - Estonia - Ravimiamet

teva pharma b.v. - kvetiapiin - toimeainet prolongeeritult vabastav tablett - 400mg 50tk; 400mg 30tk; 400mg 20tk; 400mg 60tk

Estonia - Estonia - Ravimiamet

woerwag pharma gmbh & co. kg - moksonidiin - õhukese polümeerikattega tablett - 0,3mg 10tk; 0,3mg 50tk; 0,3mg 20tk; 0,3mg 30tk; 0,3mg 100tk; 0,3mg 98tk; 0,3mg 28tk

Estonia - Estonia - Ravimiamet

woerwag pharma gmbh & co. kg - moksonidiin - õhukese polümeerikattega tablett - 0,4mg 20tk; 0,4mg 100tk; 0,4mg 50tk; 0,4mg 30tk; 0,4mg 400tk; 0,4mg 98tk

Estonia - Estonia - Ravimiamet

woerwag pharma gmbh & co. kg - moksonidiin - õhukese polümeerikattega tablett - 0,2mg 100tk; 0,2mg 20tk; 0,2mg 98tk; 0,2mg 10tk; 0,2mg 400tk; 0,2mg 30tk

Kesatuan Eropah - Estonia - EMA (European Medicines Agency)

mylan ireland limited - asatsitidiin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastilised ained - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.

Kesatuan Eropah - Estonia - EMA (European Medicines Agency)

mylan ire healthcare limited - pretomanid - tuberkuloos, multidrug-resistentne - antimükobakterid - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid.